Newsletter | July 31, 2025

07.31.25 -- Tales From The Trenches: Developing Potency Assays Outside Big Pharma

FOCUS ON OUTSOURCING

Tales From The Trenches: Developing Potency Assays Outside Big Pharma

Lessons learned from developing potency assays to detect activity and variation for cell- and receptor-mediated products — beyond the comforts of a well-heeled company.

Unravelling The Complexities Of ADC Development And Manufacturing

Whether you're in the early stages of development or scaling up for commercialization, understanding ADC manufacturing challenges is essential for bringing life-saving therapies to patients worldwide.

Why Partnerships Are Key To Harnessing New Sterile Delivery Methods

By leveraging the expertise of CDMOs, pharmaceutical firms can expedite their time to market, reduce costs, and improve patient outcomes, ultimately advancing the future of drug delivery methods.

Application Of Plant And Process Models

Explore innovative process and facility models that optimize efficiency, sustainability, and cost-effectiveness in biopharmaceutical manufacturing.

How Real-Time Data Access Enhances Collaboration With Your CDMO

Quality data for informed decision-making is well supported by a built-in network of lab digitization solutions and a commitment to the principles of data integrity.

OUTSOURCING SOLUTIONS

mRNA/LNP Development And Manufacturing Services - Lonza

CDO Services: Agile. Flexible. Focused On You. - Samsung Biologics

in vitro Kill Rate Studies For Antimicrobial Screening - Aragen

Capacity Update October 2024: Large Molecule Drug Substance - Cytovance Biologics

Connect With Bioprocess Online: